DaShenLin Pharmaceutical Group Co Ltd Class A 603233
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 22.26
- Day Range
- CNY 22.12–22.67
- 52-Week Range
- CNY 19.83–30.22
- Bid/Ask
- CNY 0.00 / CNY 0.00
- Market Cap
- CNY 25.70 Bil
- Volume/Avg
- 6.8 Mil / 8.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.77
- Price/Sales
- 1.05
- Dividend Yield (Trailing)
- 2.66%
- Dividend Yield (Forward)
- 2.66%
- Total Yield
- 2.66%
Company Profile
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 45,466
- Website
- http://www.dslyy.com
Comparables
Valuation
|
Metric
|
603233
|
600993
|
600211
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.77 | 32.64 | 10.55 |
Price/Book Value | 3.52 | 3.37 | 3.45 |
Price/Sales | 1.05 | 4.05 | 4.30 |
Price/Cash Flow | 7.29 | 17.51 | 11.31 |
Price/Earnings
603233
600993
600211
Financial Strength
|
Metric
|
603233
|
600993
|
600211
|
|---|---|---|---|
Quick Ratio | 0.58 | 6.26 | 2.75 |
Current Ratio | 0.97 | 7.29 | 2.87 |
Interest Coverage | 22.03 | 32.00 | 82.65 |
Quick Ratio
603233
600993
600211
Profitability
|
Metric
|
603233
|
600993
|
600211
|
|---|---|---|---|
Return on Assets (Normalized) | 4.63% | 8.13% | 15.20% |
Return on Equity (Normalized) | 15.28% | 11.43% | 21.09% |
Return on Invested Capital (Normalized) | 7.38% | 8.64% | 17.25% |
Return on Assets
603233
600993
600211
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Hzfjyxvy | Rgw | $585.2 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Fpqkrnx | Kyzgx | $110.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Xlpcsblw | Wlgnpj | $107.6 Bil | |
MRNA
| Moderna Inc | Lxmmsbhlc | Tfsb | $48.2 Bil | |
BNTX
| BioNTech SE ADR | Dpprvrgl | Zdq | $22.3 Bil | |
ARGX
| argenx SE ADR | Lwrybqfg | Kbyqg | $21.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Bvwmpfwy | Pzrwny | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Qsbbycwns | Gbkyss | $15.1 Bil | |
INCY
| Incyte Corp | Jrpscjslw | Kqmxy | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Jyxngnyrvm | Skyljq | $12.7 Bil |